NCT03057236 is a NA clinical trial of Cognitive Behavior Coping Skills in Hepatitis C, sponsored by University of North Carolina, Chapel Hill.

Who is sponsoring NCT03057236?

NCT03057236 is sponsored by University of North Carolina, Chapel Hill.

What drugs are being tested in NCT03057236?

Interventions in NCT03057236: Cognitive Behavior Coping Skills.

What condition does NCT03057236 study?

NCT03057236 studies Hepatitis C, Hepatitis C, Chronic.

Is NCT03057236 still recruiting?

NCT03057236 is currently completed. Last updated 20 February 2017.

Last reviewed 2017-02-20 · How we verify

NCT03057236

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pilot Feasibility Study of a Cognitive Behavioral Coping Skills (CBCS) Group Intervention for Hep C Therapy Patients

Completed NA Last updated 20 February 2017

What this trial tests

NA trial testing Cognitive Behavior Coping Skills in Hepatitis C in 20 participants. Completed in 31 December 2014.

Timeline

1 March 2014

Primary endpoint
31 December 2014

31 December 2014

Quick facts

Lead sponsor	University of North Carolina, Chapel Hill
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	1 March 2014
Primary completion	31 December 2014
Estimated completion	31 December 2014
Sites	1 location across United States

Drugs / interventions tested

Cognitive Behavior Coping Skills

Conditions studied

Hepatitis C — all drugs for Hepatitis C →
Hepatitis C, Chronic — all drugs for Hepatitis C, Chronic →

Sponsor

University of North Carolina, Chapel Hill

Who can join

21 and older, any sex, with Hepatitis C or Hepatitis C, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a pilot feasibility study of a small randomized controlled trial (RCT)design to evaluate participation in a Cognitive Behavioral Coping Skills (CBCS) group intervention versus standard of care in patients with hepatitis C undergoing antiviral treatment. The primary objectives are to (1) examine effect size (ES) estimates of key outcomes to provide essential data to inform a larger efficacy trial, (2) determine whether clinically significant improvements occurred in any key outcomes, and (3) evaluate study feasibility and patient acceptability. Study findings will inform a larger efficacy study of the CBCS-HCV.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Novel patient-reported outcomes (PROs) used in a pilot and feasibility study of a Cognitive Behavioral Coping Skills (CBCS) group intervention for patients with chronic hepatitis C.
Evon DM, Golin CE, Ruffin R, Ayres S, et al · · 2018 · cited 5× · PMID 29983993 · DOI 10.1186/s40814-018-0285-5

Verify or expand the search:

Other recruiting trials for Hepatitis C

Currently open trials in the same condition.

NCT06263829 — HCV Tappt Adherence Study · NA · recruiting
NCT06179498 — Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs · NA · recruiting
NCT06367465 — Feasibility and Acceptability of HCV Treatment in Pregnancy · recruiting
NCT05668780 — Buprenorphine Integration Research and Community Health · NA · active not recruiting
NCT05208697 — Tele-Harm Reduction · NA · active not recruiting

Other University of North Carolina, Chapel Hill trials

Trials by the same sponsor.

NCT06841913 — Woodsmoke Exposure, Influenza Infection, and Nasal Immunity · Phase 4 · suspended
NCT07383428 — The INICIO-Guatemala Study · NA · not yet recruiting
NCT07528443 — Ultraprocessed Foods in Colombia · NA · not yet recruiting
NCT07507370 — CARED : A Novel Rapid Treatment Paradigm for Depression · NA · not yet recruiting
NCT07534254 — Piloting a Generative Artificial Intelligence Chatbot in a Mobile Weight Loss Program · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03057236 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of North Carolina, Chapel Hill
Last refreshed: 20 February 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03057236.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing